View the latest content of the CAR-TCR Series

Survey Results

CAR-TCR Industry Survey Results 2019

Here’s what your peers think about key developments and priorities in this rapidly evolving field.
CAR-TCR Asia - Survey Results Snippet

CAR-TCR Conversion with...

Peter Emtage, Senior Vice President, Head of Cell Therapy Research, Kite, a Gilead Company

In this conversation, Peter shares his views on the clinical and commercial progression of CAR-T therapies after a whirlwind few years.

CAR-TCR Conversation with...

David Sourdive, Executive Vice President, Technical Operations & Co-founder, Cellectis

In this conversation, David discusses the disruptive genetic engineering approaches developed to create efficacious, next generation CAR and TCR therapies.
David Interview Thumbnail